In this study, we demonstrated that enriched iNKT cells are preferentially cytotoxic to breast cancer cells with increased CD1d expression in vitro, and this effect could be partially abrogated by the addition of anti-CD1d blocking antibody. The gene discussed is CD1D; the disease is breast carcinoma.